Ellis Investment Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-61
Closed -$10K 497
2022
Q3
$10K Hold
61
﹤0.01% 572
2022
Q2
$12K Hold
61
﹤0.01% 558
2022
Q1
$13K Hold
61
﹤0.01% 580
2021
Q4
$16K Hold
61
﹤0.01% 565
2021
Q3
$14K Hold
61
﹤0.01% 563
2021
Q2
$14K Hold
61
﹤0.01% 558
2021
Q1
$13K Hold
61
﹤0.01% 547
2020
Q4
$11K Hold
61
﹤0.01% 558
2020
Q3
$9K Hold
61
﹤0.01% 571
2020
Q2
$8K Hold
61
﹤0.01% 568
2020
Q1
$6K Buy
+61
New +$8.79K ﹤0.01% 549

Other funds holding LH

Ellis Investment Partners's LH Position: Q4 2022 in Review

Ellis Investment Partners sold out of Labcorp (LH) in Q4 2022, closing a stake of 61 shares — an estimated $10K sold.

Ellis Investment Partners first reported a position in LH in Q1 2020 and held it in 11 quarters. The position peaked at $16K in Q4 2021. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Ellis Investment Partners reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 61 Labcorp shares in Q4 2022, an estimated $10K.
  • Ellis Investment Partners first reported a position in Labcorp in Q1 2020 and held it in 11 quarters.
  • Ellis Investment Partners's Labcorp position peaked at $16K in Q4 2021.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.